u 74389f has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angel, MF; Babovic, S; Dellon, AL; Im, MJ; Manson, PN; Ress, AM | 1 |
| Jordan, M; Pieper, GM; Roza, AM | 1 |
| Rauscher, FM; Sanders, RA; Watkins, JB | 1 |
3 other study(ies) available for u 74389f and Alloxan Diabetes
| Article | Year |
|---|---|
Free radical damage in acute nerve compression.
Topics: Animals; Antioxidants; Deferoxamine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Free Radicals; Lipid Peroxidation; Malondialdehyde; Nerve Compression Syndromes; Pregnatrienes; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sciatic Nerve | 1995 |
Chronic treatment with the 21-aminosteroid U74389F, an inhibitor of lipid peroxidation, does not prevent diabetic endothelial dysfunction.
Topics: Acetylcholine; Animals; Antioxidants; Aorta, Thoracic; Blood Glucose; Body Weight; Calcimycin; Catalase; Diabetes Mellitus, Experimental; Endothelium, Vascular; Glycated Hemoglobin; Insulin; Lipid Peroxides; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Pregnatrienes; Rats; Rats, Inbred Lew; Streptozocin | 1997 |
Effects of new antioxidant compounds PNU-104067F and PNU-74389G on antioxidant defense in normal and diabetic rats.
Topics: Animals; Antioxidants; Body Weight; Diabetes Mellitus, Experimental; Liver; Male; Organ Size; Pregnatrienes; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley | 2000 |